Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Smoking Cessation 1Hematuria 1Carcinoma, Transitional Cell 1

Interventions

Magnetic Resonance Spectroscopy 107Specimen Handling 89pembrolizumab 82enzalutamide 65Nivolumab 64Gemcitabine 59Docetaxel 51Abiraterone Acetate 44apalutamide 43Radiosurgery 43Androgen Antagonists 43Prednisone 42darolutamide 40Cisplatin 38Biopsy 38cabozantinib 34Radiotherapy 34Carboplatin 30abiraterone 29Pluvicto 29Ipilimumab 29durvalumab 25enfortumab vedotin 24Leuprolide 24X-Rays 23Radiation 23atezolizumab 22olaparib 20Standard of Care 20avelumab 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinalysis × Genitourinary × 90 days × Clear all
NCT05646485 2026-05-01

Bladder Cancer Screening Trial

University of Texas Southwestern Medical Center

Phase NA Recruiting
1,000 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡